Cargando…

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care

BACKGROUND AND AIMS: The multichannel blocker dronedarone is currently indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (AF), with careful monitoring of cardiac, hepatic and renal functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goette, Andreas, Benninger, G., Pittrow, D., Paar, W.D., von Stritzky, B., Bosch, R.F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480946/ https://www.ncbi.nlm.nih.gov/pubmed/25750090 http://dx.doi.org/10.1007/s00399-015-0360-z

Ejemplares similares

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010)

Dronedarone for atrial fibrillation: a new therapeutic agent
por: Patel, Pawan D, et al.
Publicado: (2009)

Management of atrial fibrillation: focus on the role of dronedarone
por: Cheng, Judy WM
Publicado: (2011)

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
por: Schweizer, Patrick A, et al.
Publicado: (2011)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010)

Cost considerations in the management of atrial fibrillation – impact of dronedarone
por: Khaykin, Yaariv, et al.
Publicado: (2012)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
por: Trigo, Paula, et al.
Publicado: (2012)

Elevated liver enzymes associated with dronedarone for atrial fibrillation
por: Ragucci, Kelly R
Publicado: (2013)

Dronedarone-induced Phototoxicity in a Patient with Atrial Fibrillation
por: Datar, Praveen, et al.
Publicado: (2019)

Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation
por: Saengklub, Nakkawee, et al.
Publicado: (2017)

Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study
por: Blomström‐Lundqvist, Carina, et al.
Publicado: (2020)

Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
por: Wharton, John Marcus, et al.
Publicado: (2022)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS
por: Naccarelli, Gerald V, et al.
Publicado: (2014)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Publicado: (2022)

Addressing the management of atrial fibrillation – a systematic review of the role of dronedarone
por: Podda, Gian Marco, et al.
Publicado: (2012)

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
por: Sullivan, Renee M, et al.
Publicado: (2010)

Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone
por: Chahal, C Anwar A, et al.
Publicado: (2012)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
por: Zhang, Mengran, et al.
Publicado: (2021)

Amiodarone vs Dronedarone for Atrial Fibrillation: A Retrospective Cohort Study
por: Brophy, James M., et al.
Publicado: (2022)

Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter
por: Kim, Michael H., et al.
Publicado: (2014)

Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study
por: Vamos, Mate, et al.
Publicado: (2019)

Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study
por: Torp-Pedersen, Christian, et al.
Publicado: (2011)

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
por: Parhofer, Klaus G., et al.
Publicado: (2019)

Dronedarone for Atrial Fibrillation Prophylaxis in Patients Undergoing Open Heart Surgical Interventions: A Case Series
por: Patel, Jay D., et al.
Publicado: (2022)

Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies
por: Naccarelli, Gerald V., et al.
Publicado: (2020)

Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics
por: Tave, Arlene, et al.
Publicado: (2021)

Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial
por: Marrouche, Nassir F., et al.
Publicado: (2021)

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
por: Van Ganse, Eric, et al.
Publicado: (2020)

Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta‐analysis
por: Singh, Jagmeet P., et al.
Publicado: (2023)

Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies
por: Thind, Munveer, et al.
Publicado: (2022)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study
por: Lip, Gregory Y.H., et al.
Publicado: (2018)

Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS‐ADONIS trials
por: Thind, Munveer, et al.
Publicado: (2022)

Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial
por: Blomström-Lundqvist, Carina, et al.
Publicado: (2023)

Cross-talk between macrophages and atrial myocytes in atrial fibrillation
por: Sun, Zewei, et al.
Publicado: (2016)

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
por: Nabauer, Michael, et al.
Publicado: (2009)

Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
por: Ivany, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_stbrlinak7ov9qq25e0ljgfo8a